Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas
- 1 October 1974
- Vol. 34 (4) , 985-992
- https://doi.org/10.1002/1097-0142(197410)34:4<985::aid-cncr2820340402>3.0.co;2-u
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Epipodophyllotoxin VP 16213 in Treatment of Acute Leukaemia--Haematosarcoma and Solid TumoursBMJ, 1973
- Nomenclature, Methodology and Results of Clinical Trials in Acute LeukemiasPublished by Springer Nature ,1973
- Clinical Screening of Epipodophyllotoxin VM26 in Malignant Lymphomas and Solid TumoursBMJ, 1972
- 4′-Demethyl-epipodophyllotoxin thenylidene glucoside (VM 26), a podophyllum compound with a new mechanism of actionPublished by Elsevier ,1970
- The time factor in cancer chemotherapyPublished by Elsevier ,1970